Concepts (258)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hallucinogens | 3 | 2023 | 180 | 2.040 |
Why?
|
| Cannabis | 3 | 2023 | 432 | 1.610 |
Why?
|
| Substance Withdrawal Syndrome | 3 | 2022 | 633 | 1.190 |
Why?
|
| Magnetic Resonance Spectroscopy | 18 | 2020 | 3760 | 0.650 |
Why?
|
| gamma-Aminobutyric Acid | 6 | 2023 | 1123 | 0.570 |
Why?
|
| Glutamic Acid | 5 | 2023 | 1167 | 0.520 |
Why?
|
| Magnetic Resonance Imaging | 23 | 2023 | 35342 | 0.510 |
Why?
|
| Muscle, Skeletal | 6 | 2013 | 4933 | 0.480 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2022 | 997 | 0.440 |
Why?
|
| Gyrus Cinguli | 5 | 2023 | 1088 | 0.430 |
Why?
|
| Protons | 5 | 2022 | 1126 | 0.380 |
Why?
|
| Manganese | 3 | 2008 | 408 | 0.350 |
Why?
|
| Diuresis | 3 | 2005 | 116 | 0.350 |
Why?
|
| Organophosphorus Compounds | 3 | 2000 | 215 | 0.350 |
Why?
|
| Contrast Media | 6 | 2014 | 5295 | 0.340 |
Why?
|
| Body Fluids | 2 | 2008 | 319 | 0.340 |
Why?
|
| Fludrocortisone | 1 | 2008 | 25 | 0.330 |
Why?
|
| Oxygen Consumption | 3 | 2012 | 1869 | 0.320 |
Why?
|
| Organometallic Compounds | 5 | 2000 | 665 | 0.320 |
Why?
|
| Nifedipine | 1 | 2008 | 226 | 0.310 |
Why?
|
| Leg | 2 | 2012 | 1110 | 0.300 |
Why?
|
| Pyridoxal Phosphate | 2 | 2004 | 127 | 0.300 |
Why?
|
| Edetic Acid | 2 | 2004 | 277 | 0.290 |
Why?
|
| Body Water | 3 | 2005 | 343 | 0.280 |
Why?
|
| Sodium | 2 | 2008 | 1627 | 0.240 |
Why?
|
| Osseointegration | 2 | 2023 | 276 | 0.240 |
Why?
|
| Brain Mapping | 5 | 2021 | 6669 | 0.230 |
Why?
|
| Brain | 9 | 2023 | 26343 | 0.210 |
Why?
|
| Depressive Disorder | 1 | 2015 | 3748 | 0.210 |
Why?
|
| Osteogenesis | 3 | 2023 | 1299 | 0.200 |
Why?
|
| Muscles | 1 | 2006 | 1617 | 0.200 |
Why?
|
| Heterocyclic Compounds, 1-Ring | 1 | 2001 | 65 | 0.190 |
Why?
|
| Phosphates | 2 | 2015 | 786 | 0.190 |
Why?
|
| Fluorescent Dyes | 2 | 2020 | 1915 | 0.190 |
Why?
|
| Body Temperature | 2 | 2001 | 776 | 0.190 |
Why?
|
| Chelating Agents | 1 | 2001 | 380 | 0.180 |
Why?
|
| Stomach | 1 | 2004 | 697 | 0.170 |
Why?
|
| Boron Neutron Capture Therapy | 1 | 1999 | 51 | 0.170 |
Why?
|
| Metals, Rare Earth | 1 | 1998 | 17 | 0.170 |
Why?
|
| Neural Pathways | 3 | 2019 | 2971 | 0.160 |
Why?
|
| Glutamine | 1 | 2021 | 574 | 0.160 |
Why?
|
| Boron Compounds | 1 | 1999 | 178 | 0.160 |
Why?
|
| Magnetite Nanoparticles | 1 | 2020 | 322 | 0.160 |
Why?
|
| Dextrans | 1 | 2020 | 592 | 0.160 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2018 | 134 | 0.150 |
Why?
|
| Signal Processing, Computer-Assisted | 3 | 2001 | 1538 | 0.150 |
Why?
|
| Fructose | 1 | 1999 | 288 | 0.150 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 1999 | 358 | 0.150 |
Why?
|
| Temperature | 3 | 2001 | 2207 | 0.150 |
Why?
|
| Corpus Striatum | 1 | 2023 | 1220 | 0.140 |
Why?
|
| Dopamine | 1 | 2023 | 1589 | 0.130 |
Why?
|
| Phantoms, Imaging | 4 | 2001 | 2466 | 0.130 |
Why?
|
| Ferric Compounds | 2 | 2020 | 374 | 0.130 |
Why?
|
| Hydrocortisone | 1 | 2023 | 1825 | 0.130 |
Why?
|
| Dental Implants | 1 | 2023 | 749 | 0.120 |
Why?
|
| Cocaine-Related Disorders | 1 | 2017 | 460 | 0.120 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2014 | 2552 | 0.120 |
Why?
|
| Gadolinium DTPA | 3 | 2004 | 836 | 0.120 |
Why?
|
| Tuberculosis | 2 | 2020 | 1904 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2013 | 11695 | 0.110 |
Why?
|
| Altitude | 1 | 2014 | 161 | 0.110 |
Why?
|
| Molecular Imaging | 1 | 2020 | 831 | 0.110 |
Why?
|
| Image Enhancement | 5 | 2008 | 2921 | 0.110 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2018 | 721 | 0.110 |
Why?
|
| Phosphocreatine | 1 | 2013 | 269 | 0.110 |
Why?
|
| Liver | 2 | 2008 | 7470 | 0.100 |
Why?
|
| Antibodies, Bacterial | 2 | 2020 | 1469 | 0.100 |
Why?
|
| Kidney | 2 | 2004 | 7167 | 0.090 |
Why?
|
| Oxidative Phosphorylation | 1 | 2013 | 480 | 0.090 |
Why?
|
| Abdomen | 1 | 1996 | 1107 | 0.090 |
Why?
|
| Ubiquinone | 1 | 2012 | 188 | 0.090 |
Why?
|
| Cocaine | 2 | 2017 | 1008 | 0.090 |
Why?
|
| Putamen | 1 | 2011 | 291 | 0.090 |
Why?
|
| Creatine Kinase | 1 | 2012 | 694 | 0.090 |
Why?
|
| Humans | 37 | 2023 | 742088 | 0.090 |
Why?
|
| Diabetic Neuropathies | 1 | 2013 | 410 | 0.090 |
Why?
|
| Rats | 5 | 2023 | 24265 | 0.080 |
Why?
|
| Bone and Bones | 1 | 2020 | 2575 | 0.080 |
Why?
|
| Executive Function | 1 | 2017 | 1362 | 0.080 |
Why?
|
| Antifungal Agents | 1 | 2013 | 729 | 0.080 |
Why?
|
| Chondrogenesis | 1 | 2010 | 247 | 0.080 |
Why?
|
| Carbon Tetrachloride | 1 | 2008 | 64 | 0.080 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2010 | 350 | 0.080 |
Why?
|
| Joints | 1 | 2010 | 326 | 0.080 |
Why?
|
| Breast | 2 | 1996 | 1958 | 0.080 |
Why?
|
| Triazoles | 1 | 2013 | 907 | 0.080 |
Why?
|
| Diabetic Angiopathies | 1 | 2013 | 820 | 0.080 |
Why?
|
| Kidney Medulla | 2 | 2005 | 182 | 0.080 |
Why?
|
| Water | 3 | 2004 | 1388 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2023 | 5705 | 0.070 |
Why?
|
| Adult | 18 | 2023 | 213712 | 0.070 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2020 | 1825 | 0.070 |
Why?
|
| Attention | 1 | 2016 | 2396 | 0.060 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2020 | 1625 | 0.060 |
Why?
|
| Phosphorus | 2 | 2014 | 338 | 0.060 |
Why?
|
| Membrane Fluidity | 1 | 2004 | 73 | 0.060 |
Why?
|
| Nerve Net | 1 | 2017 | 2174 | 0.060 |
Why?
|
| Duodenogastric Reflux | 1 | 2004 | 5 | 0.060 |
Why?
|
| Chondrocytes | 1 | 2010 | 803 | 0.060 |
Why?
|
| Molecular Structure | 2 | 1999 | 1907 | 0.060 |
Why?
|
| Animals | 14 | 2023 | 168561 | 0.060 |
Why?
|
| Affect | 1 | 2012 | 1473 | 0.060 |
Why?
|
| West Nile Fever | 1 | 2004 | 78 | 0.060 |
Why?
|
| Depressive Disorder, Major | 1 | 2021 | 4628 | 0.060 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2004 | 205 | 0.060 |
Why?
|
| Swine | 2 | 2004 | 5934 | 0.060 |
Why?
|
| Dexamethasone | 1 | 2010 | 1949 | 0.050 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2005 | 320 | 0.050 |
Why?
|
| Cyclooxygenase 2 | 1 | 2005 | 611 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 2006 | 0.050 |
Why?
|
| Peripheral Arterial Disease | 1 | 2013 | 1184 | 0.050 |
Why?
|
| Reference Values | 2 | 2014 | 4982 | 0.050 |
Why?
|
| Rest | 2 | 2017 | 900 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2011 | 10943 | 0.050 |
Why?
|
| Bipolar Disorder | 2 | 2012 | 5024 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2013 | 2933 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 2018 | 4823 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2023 | 8300 | 0.050 |
Why?
|
| Cell Differentiation | 3 | 2020 | 11470 | 0.050 |
Why?
|
| Nanoparticles | 1 | 2012 | 1902 | 0.050 |
Why?
|
| Young Adult | 5 | 2023 | 56350 | 0.050 |
Why?
|
| Titanium | 1 | 2023 | 494 | 0.050 |
Why?
|
| Maxilla | 1 | 2023 | 469 | 0.050 |
Why?
|
| Integrin alpha5beta1 | 1 | 2020 | 38 | 0.050 |
Why?
|
| Deuterium Oxide | 1 | 1999 | 34 | 0.040 |
Why?
|
| Mitochondria | 1 | 2013 | 3520 | 0.040 |
Why?
|
| Male | 13 | 2023 | 349538 | 0.040 |
Why?
|
| Middle Aged | 10 | 2017 | 213127 | 0.040 |
Why?
|
| Durapatite | 1 | 2020 | 161 | 0.040 |
Why?
|
| Thulium | 1 | 1998 | 21 | 0.040 |
Why?
|
| Pentetic Acid | 2 | 1996 | 213 | 0.040 |
Why?
|
| Wound Healing | 1 | 2010 | 2781 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2004 | 1372 | 0.040 |
Why?
|
| Ultrasonic Therapy | 1 | 2000 | 235 | 0.040 |
Why?
|
| Deuterium | 1 | 1998 | 101 | 0.040 |
Why?
|
| Models, Chemical | 2 | 1998 | 626 | 0.040 |
Why?
|
| Germany | 1 | 2020 | 860 | 0.040 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 1998 | 165 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2008 | 5062 | 0.040 |
Why?
|
| Female | 16 | 2023 | 379592 | 0.040 |
Why?
|
| Aged | 7 | 2015 | 162944 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 1999 | 8829 | 0.040 |
Why?
|
| Hydrogen | 1 | 1998 | 164 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 2020 | 19862 | 0.040 |
Why?
|
| Particle Size | 2 | 2020 | 1640 | 0.040 |
Why?
|
| Cell Movement | 1 | 2010 | 5212 | 0.040 |
Why?
|
| Solubility | 1 | 1999 | 1083 | 0.040 |
Why?
|
| Injections, Intravenous | 1 | 2020 | 1420 | 0.040 |
Why?
|
| Models, Anatomic | 1 | 2001 | 690 | 0.040 |
Why?
|
| Hyperthermia, Induced | 1 | 2000 | 401 | 0.040 |
Why?
|
| Calcium | 2 | 2001 | 5753 | 0.040 |
Why?
|
| Bone Development | 1 | 2020 | 483 | 0.040 |
Why?
|
| Exercise | 1 | 2013 | 5611 | 0.040 |
Why?
|
| Oxygen | 2 | 2005 | 4169 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 2023 | 1385 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2005 | 1932 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2001 | 1355 | 0.030 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2004 | 1341 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1999 | 2335 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2012 | 12695 | 0.030 |
Why?
|
| Aorta | 1 | 2002 | 2057 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2008 | 4029 | 0.030 |
Why?
|
| Models, Biological | 2 | 2010 | 9581 | 0.030 |
Why?
|
| Phosphorus Isotopes | 1 | 2014 | 126 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2005 | 1970 | 0.030 |
Why?
|
| Utah | 1 | 2014 | 126 | 0.030 |
Why?
|
| Osteoblasts | 1 | 2020 | 1163 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2010 | 10472 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2018 | 1341 | 0.030 |
Why?
|
| Models, Animal | 1 | 2000 | 2170 | 0.030 |
Why?
|
| Time Factors | 4 | 2017 | 40054 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 14720 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2017 | 780 | 0.030 |
Why?
|
| Memory, Short-Term | 1 | 2019 | 972 | 0.030 |
Why?
|
| Osteoprotegerin | 1 | 2013 | 176 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 12071 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2001 | 8925 | 0.030 |
Why?
|
| Artifacts | 2 | 2001 | 1903 | 0.020 |
Why?
|
| Data Collection | 1 | 2001 | 3339 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2004 | 4455 | 0.020 |
Why?
|
| Gadolinium | 1 | 1996 | 951 | 0.020 |
Why?
|
| Saimiri | 1 | 2011 | 330 | 0.020 |
Why?
|
| Aggrecans | 1 | 2010 | 90 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 15530 | 0.020 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2013 | 647 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2017 | 2713 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 2011 | 548 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2001 | 2896 | 0.020 |
Why?
|
| SOX9 Transcription Factor | 1 | 2010 | 146 | 0.020 |
Why?
|
| Reaction Time | 1 | 2016 | 2092 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 18006 | 0.020 |
Why?
|
| Ultrasonics | 1 | 2010 | 212 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2013 | 1653 | 0.020 |
Why?
|
| Movement | 1 | 1996 | 1470 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2013 | 1241 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2005 | 7873 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2010 | 599 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2013 | 1015 | 0.020 |
Why?
|
| Glycosaminoglycans | 1 | 2010 | 624 | 0.020 |
Why?
|
| Adolescent | 2 | 2023 | 85649 | 0.020 |
Why?
|
| Bone Marrow | 1 | 1997 | 2941 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 2885 | 0.020 |
Why?
|
| Recurrence | 1 | 2017 | 8333 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2013 | 3913 | 0.020 |
Why?
|
| Lipids | 1 | 1997 | 3302 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 4929 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2013 | 21719 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2017 | 8297 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 1889 | 0.010 |
Why?
|
| Kidney Cortex | 1 | 2004 | 186 | 0.010 |
Why?
|
| Rabbits | 1 | 2010 | 4886 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 6974 | 0.010 |
Why?
|
| Brachial Artery | 1 | 2004 | 370 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2011 | 6365 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 21821 | 0.010 |
Why?
|
| Depression | 1 | 2021 | 7733 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2012 | 6030 | 0.010 |
Why?
|
| Thermometers | 1 | 2001 | 46 | 0.010 |
Why?
|
| Collagen | 1 | 2010 | 2684 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 4414 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 16665 | 0.010 |
Why?
|
| Massachusetts | 1 | 2014 | 8662 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 2004 | 1150 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6171 | 0.010 |
Why?
|
| Fourier Analysis | 1 | 2001 | 447 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2004 | 1525 | 0.010 |
Why?
|
| Placebos | 1 | 2004 | 1677 | 0.010 |
Why?
|
| Thermodynamics | 1 | 2001 | 594 | 0.010 |
Why?
|
| Vasodilation | 1 | 2004 | 944 | 0.010 |
Why?
|
| Microcirculation | 1 | 2004 | 1285 | 0.010 |
Why?
|
| Swine, Miniature | 1 | 2001 | 961 | 0.010 |
Why?
|
| Mice | 2 | 2018 | 81045 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 2002 | 981 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2010 | 5978 | 0.010 |
Why?
|
| Echo-Planar Imaging | 1 | 2001 | 659 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 20086 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 7721 | 0.010 |
Why?
|
| Knee | 1 | 1997 | 274 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2010 | 13029 | 0.010 |
Why?
|
| Dysprosium | 1 | 1994 | 25 | 0.010 |
Why?
|
| Polystyrenes | 1 | 1994 | 112 | 0.010 |
Why?
|
| Gestational Age | 1 | 2001 | 3490 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2004 | 8621 | 0.010 |
Why?
|
| Diffusion | 1 | 1994 | 832 | 0.010 |
Why?
|
| Microspheres | 1 | 1994 | 777 | 0.010 |
Why?
|
| Antipsychotic Agents | 1 | 2004 | 3058 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2005 | 12017 | 0.010 |
Why?
|
| Skin | 1 | 2004 | 4353 | 0.010 |
Why?
|
| Monte Carlo Method | 1 | 1994 | 1254 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 1996 | 20774 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 57683 | 0.000 |
Why?
|
| Risk Factors | 2 | 2004 | 72145 | 0.000 |
Why?
|
| Models, Theoretical | 1 | 1994 | 3584 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2004 | 40450 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 2001 | 25575 | 0.000 |
Why?
|
| Computer Simulation | 1 | 1994 | 6191 | 0.000 |
Why?
|
| Pregnancy | 1 | 2001 | 29087 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2004 | 62966 | 0.000 |
Why?
|
Concepts
(258)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(38)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_